Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
06:59am, Thursday, 18'th Dec 2025
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026.
BioNTech hat das Umtauschangebot zur Übernahme von CureVac abgeschlossen Die Übernahme von CureVac ergänzt BioNTechs Fähigkeiten und unternehmenseigene Technologien im Bereich mRNA-Design, Verabre
Corient Private Wealth LLC Sells 22,382 Shares of Bristol Myers Squibb Company $BMY
03:52am, Thursday, 18'th Dec 2025
Corient Private Wealth LLC decreased its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 4.2% in the undefined quarter, according to its most recent disclosure with the Securities an
These 2 Healthcare Stocks Just Declared Dividend Raises
04:40pm, Wednesday, 17'th Dec 2025
One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space.
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 17'th Dec 2025
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands , Dec. 16, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of no
AstraZeneca Gets FDA Nod For Breast Cancer Drug, EU Clearance For Lupus Pen
12:37pm, Tuesday, 16'th Dec 2025
FDA approves AstraZeneca and Daiichi's Enhertu combo for first-line HER2-positive breast cancer, while the EU clears Saphnelo self-injection for lupus.
Capital Asset Advisory Services LLC Grows Stock Position in Bristol Myers Squibb Company $BMY
05:44am, Tuesday, 16'th Dec 2025
Capital Asset Advisory Services LLC increased its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 21.9% in the undefined quarter, according to its most recent disclosure with the SEC
Final Trade: JNJ, NVO, UBER, BMY
06:22pm, Monday, 15'th Dec 2025
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.
Bristol Myers Trades At Trough Valuation — Analyst Says Pipeline Upside Is Being Ignored
12:56pm, Monday, 15'th Dec 2025
BofA Securities upgraded Bristol Myers Squibb & Co. (NYSE: BMY), citing near-term catalysts.
BMY Gains 13.1% in Three Months: Buy, Sell or Hold the Stock?
10:36am, Monday, 15'th Dec 2025
BMY shares are rebounding after a strong Q3, lifted by rising demand for Opdivo, Reblozyl and Camzyos, even as legacy drugs face generic pressure.
Pre-Market Stock Futures: Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard on Friday as investors began a big rotation last
Bristol Myers Squibb Company $BMY Shares Purchased by Cullen Capital Management LLC
05:42am, Monday, 15'th Dec 2025
Cullen Capital Management LLC lifted its position in Bristol Myers Squibb Company (NYSE: BMY) by 12.7% in the undefined quarter, according to the company in its most recent filing with the Securities
2 Dividend Stocks to Double Up on Right Now
02:47pm, Sunday, 14'th Dec 2025
These two pharmaceutical giants have faced -- or will soon face -- patent cliffs. Both are innovative drugmakers, which should allow them to overcome this issue.
The Smartest Dividend Stocks to Buy With $1,000 Right Now
12:47pm, Saturday, 13'th Dec 2025
Chevron is an integrated energy company with an impressive yield and an impressive dividend history. Bristol Myers has a high yield, but the drugmaker is out of favor.
